Laennec Inj

Laennec Injection (Laennec Inj.) is a prescription medication containing hydrolyzed human placental extract, manufactured and distributed by GC Wellbeing, one of South Korea's leading pharmaceutical companies in the wellness and regenerative medicine sector. It is indicated for the management of menopausal symptoms.

Since its launch in South Korea in 2005, Laennec Injection has become one of the country's most widely recognized placental extract injections, approaching 100 million doses distributed nationwide. It is distinguished as the only placental extract injection in Korea to have successfully passed the Korean Ministry of Food and Drug Safety (MFDS)'s rigorous post-marketing clinical re-evaluation, providing strong scientific evidence for its efficacy and safety.